What are the limitations of the pcnsl mskcc?

While the pcnsl mskcc is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the pcnsl mskcc to ensure safe bedside use and optimal diagnostic accuracy.

How does the pcnsl mskcc compare to other hematology scores?

The pcnsl mskcc is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the pcnsl mskcc free to use?

Yes. OpiCalc provides the pcnsl mskcc completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

PCNSL MSKCC Score

MSKCC PCNSL: Two-factor prognostic model for Primary CNS Lymphoma. Simple and validated independently of therapy type.

MSKCC Risk Class

Class 1 (Low)

Median Overall Survival

44 mo

Favorable clinical profile. Intensive therapy often achieves long-term durability in this class.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Prognostic stratification of newly diagnosed Primary Central Nervous System Lymphoma (PCNSL).

To guide intensity of treatment (e.g., high-dose methotrexate-based induction intensity).

Standardizing outcomes for clinical trials in CNS lymphoma.

Patient Population

Adult patients with Primary CNS Lymphoma (PCNSL).

When Not to Rely on This Score Alone

Secondary CNS Lymphoma (CNS involvement by systemic NHL) — use systemic IPI / NCCN-IPI instead.

Immunocompromised / HIV-associated PCNSL — prognosis is primarily driven by CD4 count and HAART response.

Cerebrospinal Fluid (CSF) protein level — although important, CSF protein is not part of this specific MSKCC score (but is in the IELSG score).

Section 2

Formula & Logic

Scoring variables (+1 point each)

Age > 50 years

Karnofsky Performance Status (KPS) < 70

Risk Groups

Score	Risk Group	Median Survival (mo)
0	Class 1 (Low)	44
1	Class 2 (Intermediate)	32
2	Class 3 (High)	8.5

Section 3

Pearls/Pitfalls

KPS 70 Threshold

The KPS 70 threshold (roughly equivalent to ECOG 2) is a critical pivot point in neuro-oncology. A patient with KPS < 70 cannot care for themselves, representing significant neurological disability from the tumor.

Section 4

Evidence Appraisal

Primary Score

A multivariate analysis of prognostic factors in primary central nervous system lymphoma.

Abrey LE et al. • Journal of Clinical Oncology. 2006;24(36):5711-5.

View Source

Section 5

Literature

Comparison

Developed at Memorial Sloan Kettering Cancer Center (MSKCC). It is often compared to the IELSG score (which includes age, PS, LDH, protein, and deep brain location). The MSKCC score is favored for its simplicity in clinical practice.

Last Comprehensive Review: 2026